Venture Capital

DWS slashes fees on five mutual funds, promising over $2M in annual investor savings and intensifying competition in the asset management industry.

A novel staple-like device from Inovedis gains expanded FDA approval, promising faster, less invasive repairs for a vast range of orthopedic injuries.

Biotech firm Northwest Biotherapeutics is opening a private clinic to speed up cancer therapy access, a strategic move to control its supply chain.

Fueled by a massive $110M fund, Neurophos is poaching top engineers from NVIDIA and Intel to build the future of AI with light-speed chips.

A new partnership pairs AI-powered road scans with engineering expertise, helping cash-strapped towns make data-driven infrastructure decisions.

Harrington Discovery Institute opens its 2027 award call, offering millions in funding and expert support to turn academic research into life-saving medicines.

With a new CEO known for billion-dollar deals, Modulari-T Biosciences is poised to commercialize its next-gen in vivo cell therapy platform.

From Montana party barns to historic homes, Vrbo's 2026 list reveals a new standard for trusted, experience-driven getaways for families and groups.

Biotech firm BiomEdit has secured patents for a novel biologic that uses engineered probiotics to fight a costly poultry disease, paving the way for antibiotic-free farming.

With the hire of a marketing veteran from Burger King and Chili's, the Women's Foodservice Forum signals a new era of commercial strategy for its mission.

A UK biotech's Rincell-1 therapy enters human trials, aiming to regenerate auditory nerves and restore hearing where current technology falls short.

With £21M in funding, new Focused Research Organizations, Meridial and Echo Labs, aim to tackle major bottlenecks in neuroscience and ecological intelligence.

Microsoft and North America's Building Trades Unions are launching free AI courses for millions, aiming to future-proof the skilled trades workforce.

A new report reveals South Korea's film and TV sector generated $17.1B and 291,100 jobs in 2025, a model of policy, talent, and global investment.

With a $719M war chest from its blockbuster IPO, Kailera Therapeutics is poised to challenge the dominance of Lilly and Novo in the lucrative obesity market.

The AI-native startup is transforming books into living aiBook™ experiences, aiming to reshape the $150 billion publishing industry from within.

As the global SPC flooring market booms, Boyu Machinery unveils its high-output, eco-friendly SZJZ-110 extruder, championing smart manufacturing.

SiMa.ai's Modalix SoM wins a major industry award, signaling a shift in the edge AI market toward power-efficient, on-device generative AI.

Tenvie Therapeutics begins human trials for TNV108, a drug that targets the root cause of nerve decay, offering a potential disease-modifying breakthrough.

As a key sponsor of the 2026 ATNF, Black Buffalo aims to shape the dialogue on tobacco alternatives amid rapid growth and intense regulatory scrutiny.